Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 14, 2022
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
Mon, June 13, 2022
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
Mayank Mamtani Maintained (TGTX) at Strong Buy with Decreased Target to $17 on, Jun 13th, 2022
Mayank Mamtani of B. Riley Securities, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Buy with Decreased Target from $23 to $17 on, Jun 13th, 2022.
Mayank has made no other calls on TGTX in the last 4 months.
There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 0 agree with Mayank's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Mayank
- Alec Stranahan of "B of A Securities" Initiated at Sell and Held Target at $5 on, Friday, May 20th, 2022
- Graig Suvannavejh of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $5 on, Tuesday, April 19th, 2022
- Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $19 on, Monday, April 18th, 2022
